Drug-related blood dyscrasias in a Swedish reporting system, 1985-1994

European Journal of Haematology, Supplement

Volumn 57, Issue 60, 1996, Pages 42-46

  Wiholm, Bengt Erik ^a,b   Emanuelsson, Staffan ^a  

^a MEDICAL PRODUCTS AGENCY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adverse drug reactions; Blood dyscrasias; Drugs; Spontaneous reporting

Indexed keywords

ACETAZOLAMIDE; CLOZAPINE; COTRIMOXAZOLE; DAPSONE; FUROSEMIDE; MIANSERIN; SALAZOSULFAPYRIDINE; SULFONAMIDE;

ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; APLASTIC ANEMIA; BLOOD DYSCRASIA; CHILD; CONFERENCE PAPER; FEMALE; HUMAN; MALE; PANCYTOPENIA; PRIORITY JOURNAL; SWEDEN; THROMBOCYTOPENIA; ARTICLE; CHEMICALLY INDUCED DISORDER; INCIDENCE; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PANCYTOPENIA; SWEDEN; THROMBOCYTOPENIA;

EID: 0029826451     PISSN: 09024506     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. VENNING GR. Identification of adverse reactions to new drugs II: how were 18 important adverse reactions discovered and with what delays. Br Med J 1983: 286: 289-292.
2. WIHOLM B-E, LINDQUIST M. The detection and evaluation of drug-induced agranulocytosis by spontaneous reports. Clinical Pharmacology and Therapeutics Conference, Stockholm, Sweden 1986, Abstr 1061.
3. EDWARDS IR, LINDQUIST M, WIHOLM B-E, NAPKE E. Quality criteria for early signals of possible adverse drug reactions. Lancet 1990: 336: 156-158.
4. BÖTTIGER L, WESTERHOLM B. Drug induced blood dyscrasias in Sweden. Br Med J 1973: 3: 3339-3343.
5. KAUFMAN DW, PARSELLS KELLY J, LEVY M, SHAPIRO S. The drug etiology of agranulocytosis and aplastic anemia. New York, Oxford: Oxford University Press, 1991.
6. KEISU M, WIHOLM B-E, PALMBLAD J. Trimethoprimsulfametoxazole associated blood dyscrasias. Ten years experience of the Swedish spontaneous reporting system. J Int Med 1990: 228: 353-360.
7. KEISU M, WIHOLM B-E, ÖST Å, MORTIMER Ö. Acetazolamide associated aplastic anemia. J Int Med 1990: 228: 627-632.
8. HÖRNSTEN P, KEISU M, WIHOLM B-E. The incidence of agranulocytosis during treatment of dermatitis herpetiformis as reported in Sweden 1972 through 1988. Arch Dermatol 1990: 26: 919-922.
9. KEISU M, EKMAN E. Sulphasalazine associated agranulocytosis in Sweden 1972-1989. Eur J Clin Pharmacol 1992: 43: 215-218.
10. KEISU M, EKMAN E, WIHOLM B-E. Comparing risk estimates of sulfur induced agranulocytosis from the Swedish Drug Monitoring System and a case control study. Eur J Clin Pharmacol 1992: 43: 211-214.
11. WESTERHOLM B. WHO Technical Report Series 1972: 498: 26-36.
12. Nordic Statistics on Medicines 1975-1977, Part II. Nordic Council on Medicines, Box 26, S-751 03 Uppsala, Sweden.
13. Swedish Drug Statistics. Apoteksbolaget S-105 14 Stockholm.
14. BÖTTIGER LE, WESTERHOLM B. Incidence and cause of aplastic anemia, haemolytic anemia, agranulocytosis and thrombocytopenia. Acta Med Scand 1981: 210: 475-479.
15. KEISU M, ÖST Å. Diagnoses in patients with severe pancytopenia, suspected of having aplastic anemia. Eur J Haematol 1990: 45: 11-14.